Treating Alzheimer's disease: Which drugs work well?
Alzheimer?s disease (AD) is the most common form of dementia among older persons in the U.S. Addressing the recent Manhattan Alzheimer?s Disease Conference, Raymond Pratt, MD, senior director, CNS Therapeutic Area, Eisai Medical Research, Teaneck, NJ, said that in the U.S., AD affects approximately 4 million people over 65 years of age. Pratt pointed out that most patients are cared for at home by relatives until the very latest stages of their disease, so therapies to prevent or delay the progression of AD are very important. The 2003 Manhattan Alzheimer?s Disease Conference was sponsored by Nymox Pharmaceutical Corporation.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
